Advertisement

Lyell Immunopharma, Inc. LYEL

Set alert

Price alert · LYEL

All alert types
10.80 USD -0.24 -2.17%

As of Nov 2, 11:16 AM ET

Bid
10.77 × 2
Ask
10.83 × 2
10.76 Day range 11.29
7.20 52-week range 45.00
YTD
-64.91%
1 year
-35.17%
Open
11.04
Prev close
11.04
Mkt cap
264.66M
Vol
23.72K
Avg vol
151.10K
EPS
-12.86
P/E
0.00
Div yield
0.00%
More statistics
Low
10.76
High
11.29
Forward P/E
-0.73
Beta
-0.48
Short ratio
6.15
Inst. own
58.79%
Dividend
0.00
Ex-div date
50-d avg
1.01
200-d avg
1.68
1y target
1.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for LYEL has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $2.58MOther Operating Income → Expenses: $1.76MExpenses → Selling, General & Admin: $9.58MExpenses → Research & Development: $39.52MGross Profit → Expenses: $4.00KRevenue → Gross Profit: $4.00KNet Loss → Expenses: $44.76MOther Income$2.58MOther Operating Income$1.76MGross Profit$4.00KNet Loss$44.76MExpenses$49.10MSelling, General & Admin$9.58MResearch & Development$39.52MRevenue$4.00K

Period ending Jun 30, 2026 · select a line to chart its history

Income statement

LYEL quarterly income statement
4.00K
4.00K
4.00K
47.34M
39.52M
9.58M
-47.34M
-44.76M
-44.76M
-44.76M
-44.76M
-1.92
-1.92
-1.92
-44.76M
-44.76M
23.36M
23.36M

Balance sheet

LYEL quarterly balance sheet
74.57M
74.57M
174.01M
131.12M
42.90M
213.54M
47.29M
311.15M
36.93M
39.87M
36.93M
77.34M
-1.69B
-158.00K
233.81M
233.81M
97.61M
36.93M
37.47M
3.88M

Cash flow

LYEL quarterly cash flow
2.22M
522.00K
-17.78M
-251.00K
522.00K
15.62M
15.87M
-33.92M
4.53M
Advertisement